FRM
Fox Run Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-18,473
| Closed | -$629K | – | 934 |
|
|
2025
Q1 | $629K | Buy |
+18,473
| New | +$629K | 0.1% | 391 |
|
|
2023
Q4 | – | Sell |
-4,511
| Closed | -$205K | – | 771 |
|
|
2023
Q3 | $205K | Sell |
4,511
-2,325
| -34% | -$106K | 0.06% | 557 |
|
|
2023
Q2 | $384K | Buy |
+6,836
| New | +$384K | 0.11% | 360 |
|
|
2020
Q1 | – | Sell |
-5,334
| Closed | -$325K | – | 169 |
|
|
2019
Q4 | $325K | Buy |
+5,334
| New | +$325K | 0.26% | 157 |
|
|
2018
Q3 | – | Sell |
-11,347
| Closed | -$667K | – | 618 |
|
|
2018
Q2 | $667K | Buy |
+11,347
| New | +$667K | 0.21% | 150 |
|